Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J F Fields

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of the Massachusetts Dental Society|January 1, 1983
Third party carrier's role in sealant useJ F Fields
The British Journal of Radiology|May 14, 1998
An unusual metastatic involvementM P Callaway, J F Fields, J Hawnaur
Immunological Communications|January 1, 1972
Prolonged survival of murine fibrosarcoma allotransplants by anti-enhancing Fab alloantibodyJ M Cruse, G K Lewis, H D Whitten, et al.
Progress in Experimental Tumor Research|January 1, 1974
Mechanisms of immunological enhancementJ M Cruse, G K Lewis, H D Whitten, et al.
Journal of the Reticuloendothelial Society|January 1, 1974
Fate of murine fibrosarcoma allografts and radiolabeled tumor-enhancing IgG2, normal (nonenhancing) IgG2 and bacterial endotoxin in endotoxin-tolerant and nontolerant miceJ M Cruse, G K Lewis, H D Whitten, et al.
Zeitschrift Fur Immunitatsforschung, Experimentelle Und Klinische Immunologie|January 1, 1972
Dissection of the immunosuppressive effect of the Fc region of tumor-enhancing IgGJ M Cruse, J T Forbes, G Y Gillespie, et al.
Zeitschrift Fur Immunitatsforschung, Experimentelle Und Klinische Immunologie|January 1, 1972
A synergistic immunosuppressive effect of endotoxin and PHA-M on immunologic enhancement in miceJ M Cruse, J T Forbes, B R Shivers, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of the Massachusetts Dental Society|January 1, 1983
Third party carrier's role in sealant useJ F Fields
The British Journal of Radiology|May 14, 1998
An unusual metastatic involvementM P Callaway, J F Fields, J Hawnaur
Immunological Communications|January 1, 1972
Prolonged survival of murine fibrosarcoma allotransplants by anti-enhancing Fab alloantibodyJ M Cruse, G K Lewis, H D Whitten, et al.
Progress in Experimental Tumor Research|January 1, 1974
Mechanisms of immunological enhancementJ M Cruse, G K Lewis, H D Whitten, et al.
Journal of the Reticuloendothelial Society|January 1, 1974
Fate of murine fibrosarcoma allografts and radiolabeled tumor-enhancing IgG2, normal (nonenhancing) IgG2 and bacterial endotoxin in endotoxin-tolerant and nontolerant miceJ M Cruse, G K Lewis, H D Whitten, et al.
Zeitschrift Fur Immunitatsforschung, Experimentelle Und Klinische Immunologie|January 1, 1972
Dissection of the immunosuppressive effect of the Fc region of tumor-enhancing IgGJ M Cruse, J T Forbes, G Y Gillespie, et al.
Zeitschrift Fur Immunitatsforschung, Experimentelle Und Klinische Immunologie|January 1, 1972
A synergistic immunosuppressive effect of endotoxin and PHA-M on immunologic enhancement in miceJ M Cruse, J T Forbes, B R Shivers, et al.
Pageof 1